Sonnet BioTherapeutics Inc (SONN)       0.28  +0.01 (+4.09%)

0.28  +0.01 (+4.09%)

US83548R1059 - Common Stock - After market: 0.2789 0 (-0.39%)

Buy % Consensus

Analysts have set a mean price target of 2.3. This target is 719.64% above the current price.
SONN was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SONN.
In the previous month the buy percentage consensus was at a similar level.
SONN was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High - 621.43% 719.64% 719.64% 837.50%

Up and Down Grades

Date Firm Action Rating
2022-02-09 BTIG Maintains Buy
2021-12-20 Chardan Capital Maintains Buy
2021-12-16 HC Wainwright & Co. Initiate Buy
2021-09-15 BTIG Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA